# Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH

> **NCT04813471** · PHASE3 · UNKNOWN · sponsor: **Lebanese American University Medical Center** · enrollment: 70 (estimated)

## Conditions studied

- Covid19
- Endothelial Dysfunction

## Interventions

- **DRUG:** Endothelial Protocol

## Key facts

- **NCT ID:** NCT04813471
- **Lead sponsor:** Lebanese American University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-20
- **Primary completion:** 2021-03-20
- **Final completion:** 2021-04-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813471, "Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04813471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*